Jin, Ying-Hui;
Zhan, Qing-Yuan;
Peng, Zhi-Yong;
Ren, Xue-Qun;
Yin, Xun-Tao;
Cai, Lin;
Yuan, Yu-Feng;
Yue, Ji-Rong;
Zhang, Xiao-Chun;
Yang, Qi-Wen;
Ji, Jianguang;
Xia, Jian;
Li, Yi-Rong;
Zhou, Fu-Xiang;
Gao, Ya-Dong;
Yu, Zhui;
Xu, Feng;
Tu, Ming-Li;
Tan, Li-Ming;
Yang, Min;
Chen, Fang;
Zhang, Xiao-Ju;
Zeng, Mei;
Zhu, Yu;
Liu, Xin-Can;
Yang, Jian;
Zhao, Dong-Chi;
Ding, Yu-Feng;
Hou, Ning;
Wang, Fu-Bing;
Chen, Hao;
Zhang, Yong-Gang;
Li, Wei;
Chen, Wen;
Shi, Yue-Xian;
Yang, Xiu-Zhi;
Wang, Xue-Jun;
Zhong, Yan-Jun;
Zhao, Ming-Juan;
Li, Bing-Hui;
Ma, Lin-Lu;
Zi, Hao;
Wang, Na;
Wang, Yun-Yun;
Yu, Shao-Fu;
Li, Lu-Yao;
Huang, Qiao;
Weng, Hong;
Ren, Xiang-Ying;
Luo, Li-Sha;
Fan, Man-Ru;
Huang, Di;
Xue, Hong-Yang;
Yu, Lin-Xin;
Gao, Jin-Ping;
Deng, Tong;
Zeng, Xian-Tao;
Li, Hong-Jun;
Cheng, Zhen-Shun;
Yao, Xiaomei;
Wang, Xing-Huan.
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness,
coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis
and treatment guidelines for clinicians caring for patients are needed. In the ...
Chimioprévention/méthodes,
Infections à coronavirus/diagnostic,
Infections à coronavirus/traitement médicamenteux,
Pneumopathie virale/diagnostic,
Pneumopathie virale/traitement médicamenteux,
Pandémies/prévention et contrôle,
Betacoronavirus/effets des médicaments et des substances chimiques,
Pratique factuelle/méthodes,
Antirétroviraux/usage thérapeutique,
Lopinavir/usage thérapeutique,
Chloroquine/usage thérapeutique,
Récepteurs à l'interleukine-6/usage thérapeutique,
Hydroxychloroquine/usage thérapeutique,
Plasma sanguin/immunologie
Moores, Lisa K;
Tritschler, Tobias;
Brosnahan, Shari;
Carrier, Marc;
Collen, Jacob F;
Doerschug, Kevin;
Holley, Aaron B;
Jimenez, David;
Gal, Gregoire Le;
Rali, Parth;
Wells, Philip.
Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of...
The purpose of this guideline is to ensure the best antibiotic management of suspected or confirmed bacterial pneumonia in adults in hospital during the COVID‑19 pandemic. This includes people presenting to hospital with moderate to severe community-acquired pneumonia and people who develop pneumonia w...
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
Diagnostic Clinique/diagnostic,
Betacoronavirus/effets des médicaments et des substances chimiques,
Infections à coronavirus/diagnostic,
Pneumopathie virale/diagnostic,
Hypoxie/diagnostic,
Acuité des besoins du patient,
Infections à coronavirus/traitement médicamenteux,
Pneumopathie virale/traitement médicamenteux,
Dexaméthasone/usage thérapeutique,
Allaitement naturel,
Antiviraux/usage thérapeutique,
Hydroxychloroquine/usage thérapeutique,
Colchicine/usage thérapeutique,
Plasma sanguin/immunologie,
Darunavir/usage thérapeutique,
Interférons/usage thérapeutique,
Pratique factuelle/méthodes
